India Exchange Filings

Poly Medicure Q2 FY27 Investor Presentation

Poly Medicure Ltd submits investor presentation reporting FY26 consolidated revenue of ₹1,875 cr and PAT of ₹321 cr

  • FY26 operating EBITDA: ₹458 cr; EBITDA margin: 24.4%.
  • Cash and cash equivalents stood at ₹839 cr as of 30 September 2026.
  • Presentation accompanied unaudited results for the quarter ended 30 September 2026; it did not provide Q2 financial figures.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.